PUMA BIOTECHNOLOGY, INC.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $36.5M | $36.2M | $29.6M | $53.5M | $54.7M | $63.0M | $69.2M | $67.3M |
| Accounts Receivable | $34.1M | $26.3M | $53.7M | $33.6M | $25.9M | $25.2M | $32.0M | $54.6M |
| Inventory | $13.3M | $8.7M | $5.5M | $9.5M | $8.6M | $8.8M | $8.7M | $2.7M |
| Total Current Assets | $145.1M | $142.3M | $162.7M | $143.6M | $136.6M | $132.5M | $147.7M | $156.8M |
| Property, Plant & Equipment | $103.0K | $124.0K | $187.0K | $305.0K | $388.0K | $474.0K | $515.0K | $601.0K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | $41.4M | — | — | — | $51.1M | — |
| Total Assets | $192.7M | $192.7M | $216.3M | $202.9M | $194.9M | $196.2M | $213.3M | $220.7M |
| Liabilities | ||||||||
| Accounts Payable | $3.1M | $8.2M | $5.1M | $6.4M | $5.4M | $6.0M | $5.5M | $7.5M |
| Total Current Liabilities | $49.8M | $59.7M | $81.3M | $82.7M | $79.1M | $86.7M | $96.1M | $110.4M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $10.9M | $10.6M | $21.7M | $32.7M |
| Total Liabilities | $54.2M | $64.3M | $86.0M | $87.6M | $90.2M | $99.1M | $121.2M | $149.6M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-1.28B | $-1.29B | $-1.28B | $-1.30B | $-1.31B | $-1.31B | $-1.31B | $-1.33B |
| Total Stockholders' Equity | $138.5M | $128.4M | $130.3M | $115.3M | $104.7M | $97.1M | $92.1M | $71.1M |